Grant Sweep

Consolidated research funding across disease areas and research fields — federal, foundation, state & industry sources in one filterable place.

← Back to opportunities
OpenR01NIDCDClinical trial: Optional / allowed

In Vivo High-Resolution Imaging for Inner Ear Visualization (R01 Clinical Trial optional)

National Institute on Deafness and Other Communication Disorders (NIDCD) · NIH Institute/Center · RFA-DC-25-005

Source: Grants.gov · View original posting ↗

Award
Up to $500K
Deadline
Oct 1, 2026
Letter of intent
Mechanism
R01
Duration
Expected awards
Funding cycle
One-time
Open date
Jan 6, 2025
Total funding
$500K total
Clinical trial
Optional / allowed
Established investigatorGovernmentHigher educationNonprofitSmall businessForeign entities

Funding context

17%of applications funded

Based on FY2025 NIDCD R01 applications (96 of 571 applications awarded).

Payline: NIH discontinued percentile paylines for 2026 under its Unified Funding Strategy ↗ — scores are now weighed in context rather than against a fixed cutoff.

NIDCD R01, FY2025 — atypical NIH funding year (multi-year upfront funding / rescinded paylines); NIH reports FY2025 success rates as not comparable to prior years.

Aggregate historical data by institute, mechanism, and fiscal year — context for planning, not a prediction for this opportunity. Source ↗

Research areas

Biomarkers & diagnostics

Auto-classified from the title and description (keyword-based) — may be imperfect.

Description

This funding opportunity aims to support the development of in vivo high-resolution structural and functional imaging technologies for the living human inner ear. Proposed projects should focus on improving the resolution of current imaging techniques or developing new imaging techniques that can visualize inner ear structures in vivo with significantly greater detail and accuracy than currently possible. Both structural and functional aspects, including visualizing dynamic elements are important to development of new and improved techniques. Projects may also focus on developing new imaging probes or contrast agents that can enhance visualization of the inner ear structures. Ultimately, research supported in response to this RFA is to encourage technologies that allow, for example, structures such as hair cells, otoliths, membranes, ions, and vasculature to be viewed in detail in awake patients in a clinical setting using non-invasive techniques. To achieve this goal, a multi-disciplinary team approach that takes advantage of the expertise of each team member is highly encouraged. Studies in humans and intermediate studies in animals, but not non-mammalian species, may be proposed to develop or advance the needed technology. Any intermediate studies must articulate a clear path of the proposed methodology to application in awake humans or define the limitations and the usefulness in anesthetized humans.